ACCESS Newswire
23 May 2023, 10:25 GMT+10
PARIS, FRANCE and BOSTON, MA / ACCESSWIRE / May 23, 2023 / TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a Series D round of financing, raising €50 million from new and existing international investors, including Fonds Stratégique des Transitions, managed by ISALT, Merieux Developpement and returning Cathay Health, Credit Mutuel Innovation and Sofinnova Partners.
This latest funding round coincides with a period of important milestones for TISSIUM, notably its on-going first-in-human study on its first nerve repair product, COAPTIUM Connect, in Australia and multiple on-going regulatory activities. The financing will allow TISSIUM to continue to execute on its development plan, funding the company for the commercialisation of its first products in nerve and hernia repair and fueling the extension of its pipeline of products and its platform.
As TISSIUM adds to its platform with products in new therapeutic areas, it will continue to pursue rapid international expansion, leveraging in-house production and state-of-the-art manufacturing facilities, as well as entering partnerships in certain verticals.
Christophe Bancel, CEO of TISSIUM, said, 'With the closing of our Series D financing round, TISSIUM is well-positioned to finance the commercialization of its first products. This funding significantly bolsters our ability to move with speed towards our goal of enhancing tissue reconstruction for patients. We look forward to continuing our work to bring innovation in the space and develop products that make a difference in patients' lives.'
About TISSIUM:
TISSIUM, a privately-owned MedTech company based in Paris, France and Boston, USA, is dedicated to the development and commercialization of products derived from its unique biopolymer platform. The company's products will address multiple unmet clinical needs, including atraumatic tissue repair and reconstruction.
TISSIUM is developing a portfolio of products that leverage its proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are the foundation of the company's technology platform. Currently, the Company has a pipeline of seven products across three verticals, including sutureless nerve repair, hernia repair and cardiovascular sealants. Each product is designed to enhance the tissue reconstruction process in a unique way. In addition, the company develops complementary delivery and activation devices for enhanced performance and usability of its products.
TISSIUM's technology is based on world-class research and intellectual property from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women's Hospital), who co-founded the company in 2013.
For more information, please visit: www.TISSIUM.com
Follow us on LinkedIn, Twitter @TISSIUMtech.
###
CONTACTS
Investor relations
Romain Attard - Chief Financial Officer [email protected]
Tel: +33 1 76 21 72 28 Twitter: @TISSIUMtech
Press
Jeanene Timberlake [email protected]
Tel: +1 646-770-8858
SOURCE: TISSIUM
Get a daily dose of Irish Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Irish Sun.
More InformationNEW YORK CITY, New York: A Delta Air Lines plane's wing hit the runway at LaGuardia Airport during a rough landing over the weekend....
AUSTIN/SANTA FE: Measles cases in Texas and New Mexico increased to 317 on March 18, up from 294 four days earlier, as the U.S. faces...
WASHINGTON, D.C.: The Trump administration is considering strict new travel restrictions for citizens of dozens of countries, according...
WASHINGTON, D.C.: The Trump administration announced this week that Maine's education officials violated federal law by allowing transgender...
NEW YORK CITY, New York: Severe storms and tornadoes continued to threaten parts of Pennsylvania, New York, and several Mid-Atlantic...
As Israeli tanks rolled into Gaza on Wednesday heralding a new ground invasion, a UN building was destroyed in a bombing, killing one...
BERLIN, Germany: Audi has announced plans to cut up to 7,500 jobs in Germany by 2029 as part of a broader restructuring aimed at reducing...
FRANKFURT, Germany: UBS CEO Sergio Ermotti will receive a pay package of just over 15 million Swiss francs (US$17 million) for 2024,...
DUBLIN, Ireland: Dublin came alive with energy and color as thousands lined the streets to celebrate St. Patrick's Day, soaking in...
DUBLIN, Ireland: Authorities in two border counties have spent over 1.6 million euros in the past five years cleaning up toxic waste...
DUBLIN, Ireland: The need to reduce regulatory burdens in the European Union is finally being acknowledged, according to Ireland's...
BERLIN, Germany: German Lawmakers are debating whether to loosen the country's strict borrowing rules to fund military expansion. ...